
20 May 2025
TruFin plc
("TruFin" or the "Company" or together with its subsidiaries the "Group")
Trading Update and Share Buyback
TruFin is pleased to announce that due to the continued strong performance of Balatro, the hit console and mobile game published by
Gross revenue for the four months ended
Following the strong start to the year and in conjunction with a review of the Company's current capital structure, the Board has determined that:
· TruFin currently holds capital in excess of its liquidity requirements;
· all high-return internal investments are fully funded and no immediate acquisition opportunities are available; and
· the Company's shares trade at a discount to an internally calculated intrinsic value.
As a result, the Board intends to shortly initiate a share buyback programme of up to
The Board remains committed to allocating capital where it generates the highest return profile for shareholders, when balanced with the risk profile of the potential returns. The Board will continue to explore reinvestment opportunities, acquisitions, and the continual returning of excess funds in a disciplined and value-enhancing manner.
"We're off to a strong start in 2025.
Playstack continues to outperform, with the success of Balatro and Abiotic Factor significantly enhancing its position as a compelling asset-whether as a standalone business or for a strategic buyer.
Given the strength of our balance sheet and the Board's view that the current share price undervalues our assets and their future prospects, we believe a share buyback is a prudent step to further enhance shareholder returns.
We remain confident in the Group's outlook for 2025 and beyond, and we look forward to updating shareholders on our continued progress throughout the year."
Notes
1 Excluding share-based payments
The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a
For further information, please contact:
|
|
|
0203 100 2000
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the